VVOS
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
时间：2024-12-23 21:00:01 市场： 美股 综合
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules
时间：2024-09-19 19:00:02 市场： 美股 综合
Vivos Therapeutics Receives Groundbreaking FDA 510(K) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
时间：2024-09-18 19:00:01 市场： 综合 美股